Does SORAFENIB Cause Palmar-plantar erythrodysaesthesia syndrome? 1,040 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,040 reports of Palmar-plantar erythrodysaesthesia syndrome have been filed in association with SORAFENIB (sorafenib). This represents 9.5% of all adverse event reports for SORAFENIB.
1,040
Reports of Palmar-plantar erythrodysaesthesia syndrome with SORAFENIB
9.5%
of all SORAFENIB reports
202
Deaths
233
Hospitalizations
How Dangerous Is Palmar-plantar erythrodysaesthesia syndrome From SORAFENIB?
Of the 1,040 reports, 202 (19.4%) resulted in death, 233 (22.4%) required hospitalization, and 24 (2.3%) were considered life-threatening.
Is Palmar-plantar erythrodysaesthesia syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SORAFENIB. However, 1,040 reports have been filed with the FAERS database.
What Other Side Effects Does SORAFENIB Cause?
Hepatocellular carcinoma (1,665)
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
Weight decreased (598)
What Other Drugs Cause Palmar-plantar erythrodysaesthesia syndrome?
CAPECITABINE (5,294)
CABOZANTINIB S-MALATE (2,706)
REGORAFENIB (1,230)
LENVATINIB (1,211)
BEVACIZUMAB (1,079)
OXALIPLATIN (980)
SUNITINIB MALATE (929)
TRASTUZUMAB (919)
FLUOROURACIL (837)
PEMBROLIZUMAB (832)
Which SORAFENIB Alternatives Have Lower Palmar-plantar erythrodysaesthesia syndrome Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK